Sign In
Buy IQV
$182.05
+1.41 (+0.781%)
At Close: Jun 03, 2026
What's in the Offing for IQVIA Holdings (IQV) in Q2 Earnings?
02:43pm, Monday, 18'th Jul 2022
IQVIA Holdings' (IQV) second-quarter 2022 earnings and revenues are likely to have risen year over year.
IQVIA Holdings (IQV) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
11:39am, Thursday, 14'th Jul 2022
IQVIA (IQV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
IQVIA to Announce Second-Quarter 2022 Results on July 21, 2022
04:15pm, Thursday, 07'th Jul 2022
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) will announce its second-quarter 2022 financial results before the market opens on Thursday, July 21, 2022.
3 Biotech Stocks to Sell Now
02:16pm, Tuesday, 05'th Jul 2022
These biotech stocks remain vulnerable to more downside. Their charts remain broken and resistance looms ominously overhead.
IQV vs. APP: Which Stock Should Value Investors Buy Now?
01:06pm, Tuesday, 28'th Jun 2022
IQV vs. APP: Which Stock Is the Better Value Option?
7 Biotech Stocks With Key Catalysts Coming in July
06:15am, Monday, 27'th Jun 2022
Biotech stocks have suffered significant setbacks during the first half of the year but are likely to bounce back soon The post 7 Biotech Stocks With Key Catalysts Coming in July appeared first on Inv
Why a Hold Strategy is Apt for IQVIA Holdings (IQV) Stock Now
02:00pm, Friday, 24'th Jun 2022
IQVIA's (IQV) enormous treasure trove of information is a distinguishing asset.
Here's Why You Should Retain IQVIA Holdings (IQV) Stock Now
03:49pm, Tuesday, 31'st May 2022
IQVIA (IQV) rides on a solid healthcare-specific global IT infrastructure and analytics-driven clinical development skills. However, a weak balance sheet is worrisome.
Why Is IQVIA (IQV) Down 5.3% Since Last Earnings Report?
12:48pm, Friday, 27'th May 2022
IQVIA (IQV) reported earnings 30 days ago. What's next for the stock?
Karen Firestone's top stock picks: Vertex Pharma, Moderna
05:24pm, Friday, 13'th May 2022
Kari Firestone, Aureus Asset Management, joins 'Closing Bell: Overtime' to discuss the biotech bounce and her top stock picks.
IQVIA (IQV) Strong on IT Infrastructure Despite Debt Woes
03:48pm, Friday, 13'th May 2022
IQVIA (IQV) rides on a solid healthcare-specific global IT infrastructure and analytics-driven clinical development skills. However, a weak balance sheet is worrisome.
Elfun Trusts Storms Into Netflix, IQVIA in 1st Quarter
05:54pm, Thursday, 05'th May 2022
Elfun Trusts (Trades, Portfolio), part of Boston-based State Street Global Advisors, disclosed its first quarter portfolio this week, revealing that its top five trades included new holdings in Netfli
IQVIA A Smart Choice In A High-Inflation Environment
11:54am, Friday, 29'th Apr 2022
IQVIA has the potential to outperform the market in a higher inflation environment. Significant growth potential with projected 17.72% FCF and 11.68% EBIT CAGR over the next 5 years.
IQVIA (IQV) Beats on Q1 Earnings & Revenues, Tweaks '22 View
02:33pm, Wednesday, 27'th Apr 2022
IQVIA's (IQV) first-quarter 2022 earnings and revenues increase year over year.
IQVIA Holdings Inc.'s (IQV) CEO Ari Bousbib on Q1 2022 Results - Earnings Call Transcript
02:28pm, Wednesday, 27'th Apr 2022
IQVIA Holdings Inc. (NYSE:IQV ) Q1 2022 Earnings Conference Call April 27, 2022 9:00 AM ET Company Participants Nick Childs - Senior Vice President, Investor Relations and Corporate Communications Ari
